Thyrocare Technologies Ltd
Thyrocare Technologies Ltd (THYROCARE) last traded at ₹598, a market capitalisation of ₹9,521 crore, on a P/E of 52.7. Over the past 52 weeks the stock has ranged between ₹343 and ₹662. Thyrocare Technologies Ltd last reported results for the quarter ended Jun 2026, with sales of ₹240 crore and net profit of ₹51 crore. Figures are as of 25 Aug 2026 and are not real time.
Thyrocare Technologies Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Thyrocare Technologies Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹240 cr, up 24.4% from ₹193 cr a year earlier. Net profit was ₹51 cr, up 34.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 177 | 166 | 187 | 193 | 217 | 196 | 224 | 240 |
| Expenses | 129 | 124 | 130 | 135 | 145 | 138 | 149 | 163 |
| Operating profit | 48 | 42 | 57 | 58 | 71 | 58 | 75 | 77 |
| OPM % | 27% | 25% | 30% | 30% | 33% | 30% | 34% | 32% |
| Other income | 3 | 4 | 5 | 5 | 3 | -1 | 5 | 5 |
| Interest | 1 | 1 | 1 | 1 | 1 | -0 | 2 | 1 |
| Depreciation | 13 | 17 | 14 | 11 | 12 | 22 | 14 | 12 |
| Profit before tax | 37 | 28 | 47 | 50 | 63 | 35 | 64 | 68 |
| Tax % | 28% | 32% | 54% | 24% | 24% | 21% | 24% | 25% |
| Net profit | 26 | 19 | 22 | 38 | 48 | 28 | 49 | 51 |
| EPS (₹) | 1.68 | 1.20 | 1.36 | 2.45 | 3.02 | 1.82 | 2.96 | 3.28 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Thyrocare Technologies Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 495 | 589 | 527 | 572 | 687 | 829 | 876 |
| Operating profit | 171 | 236 | 123 | 140 | 190 | 263 | 282 |
| OPM % | 35% | 40% | 23% | 24% | 28% | 32% | 32% |
| Net profit | 113 | 176 | 64 | 69 | 91 | 163 | 176 |
| EPS (₹) | 7.13 | 11.10 | 4.06 | 4.45 | 5.76 | 10.24 | 11.08 |
TTM is the trailing twelve months to the most recent quarter.
Thyrocare Technologies Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 11%
- 3 Years
- 16%
- TTM
- 21%
- 10 Years
- 12%
- 5 Years
- 8%
- 3 Years
- 36%
- TTM
- 70%
- 10 Years
- 12%
- 5 Years
- 7%
- 3 Years
- 48%
- 1 Year
- 38%
- 10 Years
- 21%
- 5 Years
- 20%
- 3 Years
- 20%
- Last Year
- 28%
Thyrocare Technologies Ltd shareholding pattern
Promoters held 60.92% at Jun 2026, down from 71.06% at Jun 2025. FIIs 5.43% and DIIs 20.92%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.11% | 71.06% | 71.06% | 71.06% | 71.06% | 60.93% | 60.92% | 60.92% |
| FIIs | 1.93% | 2.77% | 2.41% | 3.23% | 4.85% | 4.96% | 5.37% | 5.43% |
| DIIs | 14.79% | 14.68% | 14.97% | 14.54% | 13.47% | 20.52% | 21.00% | 20.92% |
| Public | 12.15% | 11.49% | 11.57% | 11.18% | 10.61% | 13.61% | 12.71% | 12.71% |
| No. of shareholders | 59,377 | 56,666 | 57,403 | 54,566 | 54,142 | 77,619 | 73,377 | 73,064 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Thyrocare Technologies Ltd corporate filings
- Disclosure under Regulation 30A of LODROtherslow impact
Cruxal's analysis: Thyrocare Technologies has announced the complete discharge and release of transaction…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASThigh impact
Cruxal's analysis: Thyrocare Technologies Limited has announced the complete release of a pledge on 7 crore…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACsInsider Trading / SASTmedium impact
Cruxal's analysis: Docon Technologies Private Limited, the promoter of Thyrocare Technologies Limited, has…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt LtdInsider Trading / SASThigh impact
Cruxal's analysis: Thyrocare Technologies Limited has announced that its promoter, Docon Technologies…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Mutual FundInsider Trading / SASTmedium impact
Cruxal's analysis: HSBC Mutual Fund has disclosed an acquisition of 29.99 lakh shares of Thyrocare…
Read the full analysis - The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 13, 2026 for Docon Technologies Pvt LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Thyrocare Technologies Limited's promoter, Docon Technologies Private Limited, has…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACInsider Trading / SASThigh impact
Cruxal's analysis: Thyrocare Technologies Limited's promoter, Docon Technologies Private Limited, has…
Read the full analysis - The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 17, 2026 for Docon Technologies Pvt LtdInsider Trading / SASThigh impact
Cruxal's analysis: Thyrocare Technologies Limited's promoter, Docon Technologies Private Limited, has…
Read the full analysis - Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies LimitedCompany Updatemedium impact
Cruxal's analysis: Thyrocare Technologies has received an intimation from its promoter regarding the release…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual FundInsider Trading / SASTlow impact
Cruxal's analysis: Thyrocare Technologies Ltd. has seen a reduction in shareholding by ICICI Prudential…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Thyrocare Technologies Limited has announced the release of a pledge on 1.75 crore equity…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt LtdInsider Trading / SASThigh impact
Cruxal's analysis: Thyrocare Technologies Limited promoter, Docon Technologies Private Limited, has sold 1…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACsInsider Trading / SASTmedium impact
Cruxal's analysis: Docon Technologies Private Limited, the promoter of Thyrocare Technologies Limited, has…
Read the full analysis - Communication Received From Promoter Regarding Sale Of 1,57,69,696 Equity Shares Of The Company By Promoter - Docon Technologies Private Limited.Company Updatehigh impact
Cruxal's analysis: Thyrocare Technologies Limited has disclosed that its promoter, Docon Technologies…
Read the full analysis - Please find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the CompanyCompany Updatemedium impact
Cruxal's analysis: Docon Technologies Private Limited, a promoter of Thyrocare Technologies Ltd, has…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Thyrocare Technologies Ltd
Cruxal reads every Thyrocare Technologies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.